Asieris Pharmaceuticals (688176.SH) Issued 2022 Semi-Annual Report: Accelerated Global Clinical Development and Progressive Implementation of Its Integrated Diagnosis-Treatment Commercialization Strategy

PR Newswire
August 25, 2022 — 00:46 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: America biotech China electronics Expansion finance Germany Hainan healthcare Hungary investment manufacturing medicine Netherlands Pandemic Renminbi Shanghai Ukraine

Related News:

Harbour BioMed Announces Submission of IND Application for HBM9378/SKB378 in the Treatment of Chronic Obstructive Pulmonary Disease

November 8, 2024 — 17:45

New features revealed for PaperCut Hive cloud print management solution

November 8, 2024 — 06:32

LPS Launches NeuroNode: Empowering Advanced AI for Enterprises with On-Premises LLM

November 7, 2024 — 17:39

Iconic Supermodels Helena Christensen and Sean O’Pry Lead the NYFW Debut of E-commerce Powerhouses Ekouaer and Coofandy

September 14, 2024 — 20:26

Live from ESMO 2024 | Ascentage Pharma Releases Latest Data Showing Sustained Clinical Efficacy of Olverembatinib in SDH-Deficient GIST during a Mini Oral Presentation

September 14, 2024 — 08:18

Desay Battery Highlights Advanced Energy Solutions at RE+ 2024

September 11, 2024 — 03:00

Announcement of ICAIRE’s Classification as a UNESCO Category 2 Center at the Global AI Summit

September 11, 2024 — 02:34

Transcenta Holding Limited (Stock Code: 6628.HK) Announce 2024 Interim Results

August 29, 2024 — 14:31

Telin and Indosat Ooredoo Hutchison Partner to Develop the Indonesia Cable System Express 2 (ICE System 2)

August 28, 2024 — 20:46

Franchising and Licensing Asia (FLAsia) 2024